PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 105 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $29,000,000 | -63.8% | 27,262 | 0.0% | 0.00% | – |
| Q4 2015 | $80,000,000 | +98665.4% | 27,262 | +6.7% | 0.00% | – |
| Q3 2015 | $81,000 | -99.9% | 25,545 | +0.1% | 0.00% | -100.0% |
| Q2 2015 | $151,049,000 | -32.4% | 25,515 | +22.0% | 0.00% | 0.0% |
| Q1 2015 | $223,592,000 | +13.8% | 20,916 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $196,401,000 | +17.6% | 20,916 | -3.8% | 0.00% | 0.0% |
| Q3 2014 | $166,986,000 | -14.5% | 21,743 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $195,396,000 | +206.6% | 21,759 | +82.6% | 0.00% | – |
| Q1 2014 | $63,735,000 | +117.5% | 11,913 | +2.5% | 0.00% | – |
| Q4 2013 | $29,300,000 | -8.6% | 11,627 | -1.0% | 0.00% | – |
| Q3 2013 | $32,058,000 | +27.8% | 11,743 | +69.1% | 0.00% | – |
| Q2 2013 | $25,075,000 | – | 6,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |